The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
The company will showcase the next generation of its Philisa platform, a real-time PCR system which can run four multiplexed qPCR protocols in about 20 minutes.
A proof-of-principle study has shown a new qPCR device can detect bacterial DNA in under four minutes using droplet size as a readout of amplification.
The amplification method uses light-emitting diodes and gold foil to heat the reaction mixture and achieve 30 cycles in less than five minutes.
Co-sponsored by Boeing and miniPCR, the winning high school student's project will be carried out by astronauts aboard ISS and is believed to be the first ever PCR in space.
The thermal cycler costs less than $130 to build using off-the-shelf supplies and boasts speeds of 17 seconds per cycle.
The UK-based firm is also part of a consortium developing a two-hour sepsis test.
The technology is used to regulate temperature across a PCR plate.
NEW YORK (GenomeWeb) ― Cambridge, Mass.-based Amplyus has launched a Kickstarter funding campaign intended to bring its miniPCR platform into full production and "open the world of DNA science to everyone, everywhere."
NEW YORK (GenomeWeb) — Eppendorf said today that it has licensed patents covering gradient technology for thermal cyclers to SensoQuest, including German patent Nos. DE 19655282 and DE 19655141.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.